Resolor prucalopride regulatory update

The U.K.'s NICE issued a final appraisal determination (FAD) recommending Resolor prucalopride to treat constipation in women in whom treatment with at least 2 laxatives from different classes at the highest tolerated recommended doses for at least 6 months has failed to provide adequate relief, and in whom invasive treatment for constipation is being considered. The decision is in line with an August preliminary appraisal (see BioCentury, Aug. 9). ...